Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “De Novo”

1,165 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,165 results

Not applicableUnknownNCT03268889
What this trial is testing

Chidamide With CHOP Regimen for de Novo PTCL Patients (CHOP: Cyclophosphamide, Etoposide, Vincristine and Prednisone; PTCL: Peripheral T Cell Lymphoma)

Who this might be right for
Peripheral T Cell Lymphoma
The First Affiliated Hospital of Soochow University 39
Not applicableUnknownNCT00715884
What this trial is testing

Study Comparing the CYPHER® ELITE™ to the CYPHER® Bx VELOCITY® Sirolimus-Eluting Stent Systems

Who this might be right for
Coronary Artery DiseaseCoronary Atherosclerosis
Cordis US Corp. 678
Not applicableStudy completedNCT00927940
What this trial is testing

RESOLUTE Japan - The Clinical Evaluation of the MDT-4107 Drug-Eluting Coronary Stent

Who this might be right for
Arterial Occlusive DiseasesMyocardial IschemiaCardiovascular Diseases+1 more
Medtronic Vascular 100
Not applicableStudy completedNCT00614848
What this trial is testing

The ENDEAVOR II Clinical Trial: The Medtronic Endeavor Drug Eluting Coronary Stent System in Coronary Artery Lesions

Who this might be right for
Coronary Artery DiseaseArterial Occlusive DiseasesCoronary Disease+6 more
Medtronic Vascular 1,200
Post-approval studies (Phase 4)Ended earlyNCT00522548
What this trial is testing

Myfortic or CellCept Gastrointestinal Effects in African American Kidney Recipients

Who this might be right for
Transplants and Implants
University of Pennsylvania 37
Post-approval studies (Phase 4)Study completedNCT00154193
What this trial is testing

Nordic Study in Cardiac and Lung Transplantation: Outcome in Relation to Cyclosporine Microemulsion C2 Levels

Who this might be right for
Heart and Lung Transplant
Novartis Pharmaceuticals 190
Not applicableUnknownNCT05417022
What this trial is testing

Safety and Efficacy Evaluation of Orbital Atherectomy System in de Novo Calcified Lesions

Who this might be right for
AngiographyCoronary Calcification
Centre Recherche Cardio Vasculaire Alpes 300
Not applicableStudy completedNCT02648620
What this trial is testing

Safety and Feasibility of SurModics SurVeil (TM) Drug Coated Balloon

Who this might be right for
Peripheral Arterial DiseasePeripheral Vascular Diseases
SurModics, Inc. 13
Testing effectiveness (Phase 2)Study completedNCT00027924
What this trial is testing

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Fred Hutchinson Cancer Center
Large-scale testing (Phase 3)Study completedNCT00248313
What this trial is testing

Study Comparing Cyclosporin Dose Reduction With Cyclosporin Elimination in Kidney Transplant Recipients Taking Sirolimus

Who this might be right for
Kidney Disease
Wyeth is now a wholly owned subsidiary of Pfizer 470
Testing effectiveness (Phase 2)Study completedNCT01064791
What this trial is testing

Efficacy, Safety, Tolerability, and Pharmacokinetics of Sotrastaurin Combined With Tacrolimus vs. a Mycophenolic Acid-tacrolimus Regimen in Renal Transplant Patients

Who this might be right for
Renal Transplantation
Novartis Pharmaceuticals 298
Very early researchEnded earlyNCT00361296
What this trial is testing

Vaccine Therapy in Treating Patients With Myelodysplastic Syndromes

Who this might be right for
Myelodysplastic Syndromes
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 9
Not applicableStudy completedNCT01792089
What this trial is testing

Fructose-induced Intestinal de Novo Lipogenesis

Who this might be right for
Obesity
University of Lausanne 24
Early research (Phase 1)Ended earlyNCT00996359
What this trial is testing

Partially HLA-Matched Irradiated Allogeneic Cellular Therapy After Reduced Intensity Total Body Irradiation

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
University of Medicine and Dentistry of New Jersey 4
Not applicableUnknownNCT03939468
What this trial is testing

Drug-Coated Balloon in Combination With New Generation Drug-Eluting Stent for de Novo Diffuse Disease Treatment

Who this might be right for
Coronary Artery Disease
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio 106
Not applicableNot Yet RecruitingNCT06213168
What this trial is testing

Impact on Mortality of a Strategy Including Continuous Positive Airway Pressure Plus High Flow Nasal Cannula Oxygen Therapy Versus High Flow Nasal Cannula Oxygen Therapy Alone in Patients With de Novo Acute Hypoxemic Respiratory Failure: a Prospective, Randomized Controlled Trial.

Who this might be right for
De Novo Hypoxemic Acute Respiratory Failure (hARF)
Assistance Publique - Hôpitaux de Paris 1,084
Testing effectiveness (Phase 2)Study completedNCT00731328
What this trial is testing

Donor Stem Cell Transplant After Busulfan, Fludarabine, Methylprednisolone, and Antithymocyte Globulin in Treating Patients With Bone Marrow Failure Syndrome

Who this might be right for
LeukemiaMyelodysplastic SyndromesNonmalignant Neoplasm+1 more
Asan Medical Center 15
Not applicableStudy completedNCT02086045
What this trial is testing

Elixir Medical Clinical Evaluation of the DESolve® Novolimus Eluting Bioresorbable Coronary Scaffold System - The DESolve Nx Trial

Who this might be right for
Coronary Artery Disease
Elixir Medical Corporation 126
Early research (Phase 1)Ended earlyNCT00234000
What this trial is testing

Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Jonsson Comprehensive Cancer Center 1
Large-scale testing (Phase 3)Ended earlyNCT00180544
What this trial is testing

Safety and Effectiveness Study of the HERCULINK 14 Stent to Treat Renal Artery Disease

Who this might be right for
Renal Artery Obstruction
Abbott Medical Devices 167
Load More Results